Related Experiment Video
Updated: Nov 9, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Thrombospondin 1 in Metabolic Diseases
Linda S Gutierrez1, Jovita Gutierrez1
1Department of Biology, Wilkes University, Wilkes Barre, PA, United States.
Thrombospondin 1 (TSP1) is crucial in regulating immune and metabolic processes. Recent research links TSP1 and its receptors to obesity, diabetes, and cardiovascular diseases, suggesting therapeutic potential.
Area of Science:
- Biochemistry and Molecular Biology
- Immunology
- Metabolic Disorders
Background:
- The thrombospondin family includes five glycoproteins, with thrombospondin 1 (TSP1) being the most studied.
- TSP1 is a matricellular protein with known antiangiogenic properties, inhibiting endothelial cell migration, proliferation, and inducing apoptosis.
- TSP1 plays a role in cell migration and latent transforming growth factor beta 1 (TGFβ1) activation, influencing immune processes.
Purpose of the Study:
- To highlight recent findings associating TSP1 and its receptors with metabolic disorders.
- To explore the role of TSP1 in physiological and metabolic conditions beyond cancer and inflammation.
- To identify TSP1 and its receptors as potential therapeutic targets for metabolic diseases.
Main Methods:
- Review of recent scientific literature focusing on TSP1, its receptors (CD36, CD47), and their involvement in metabolic diseases.
- Analysis of TSP1's known functions, including nitric oxide regulation and TGFβ1 activation.
- Examination of the interplay between TSP1, its receptors, and cellular metabolism.
Main Results:
- Recent data reveal a significant association between TSP1, its receptors (CD36, CD47), and conditions such as obesity, diabetes mellitus, and cardiovascular diseases.
- TSP1's functions in regulating nitric oxide and activating latent TGFβ1 are critical for its role in cell metabolism.
- Imbalances in immune regulation, influenced by TSP1, are increasingly linked to pathological conditions like obesity and diabetes.
Conclusions:
- TSP1 and its major receptors (CD36, CD47) play a vital role in cell metabolism and are implicated in metabolic diseases.
- The established functions of TSP1 in immune modulation and its newly recognized roles in metabolic health warrant further investigation.
- Targeting TSP1 and its receptors presents a promising therapeutic strategy for managing metabolic disorders.
More Related Videos
07:09Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Intracellular Signaling Affects Focal Adhesions
Some...
TGF - β Signaling Pathway
Clot Retraction and Fibrinolysis
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: